Dr. Alessandro Blasimme holds a MA in bioethics from La Sapienza University of Rome (Italy), as well as a PhD in bioethics from the University of Milan - European School of Molecular Medicine (Italy). He has held research appointments at the French National Institute of Health and Medical Research (INSERM) as well as the University of Zurich (Switzerland), before joining the Swiss Federal Institute of Technology (ETH Zurich) as a senior researcher in bioethics in 2017. In 2013 he received a Fulbright-Schuman Scholarship to undertake research at Harvard University (USA). His activities revolve around ethical and policy issues in biomedical innovation and biotechnology. His areas of expertise include stem cell biology, regenerative medicine, genetic engineering, digital health and ageing.